CorVel Corporation's stock experienced a significant drop of 5.38% during intraday trading on Tuesday. The sharp decline occurred shortly after the market opened, marking a notable downward movement for the healthcare technology company.

The price movement appears to be a reaction to the company's third-quarter fiscal year 2026 earnings release. CorVel reported quarterly revenue of $236 million, representing a 3% increase from the same period last year. Earnings per share for the quarter were $0.47, up 2% from $0.46 in the prior year's comparable quarter.

Despite reporting year-over-year growth in both revenue and earnings, the market response was negative, suggesting investors may have been expecting stronger results or were concerned about the pace of growth. The company also highlighted advancements in AI initiatives and maintained a strong cash position with no borrowings, but these positive developments were overshadowed by the earnings disappointment reflected in the stock's performance.